These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31067371)

  • 21. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V; Perales A; Meseguer J; Parrilla JJ; Lara C; Bellver J; Grifol R; Alcover I; Sala M; Martínez-Escoriza JC; Pellicer A
    BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K; Rode L; Nicolaides KH; Krampl-Bettelheim E; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
    van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC
    Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Subtil D; Brabant G; Tilloy E; Devos P; Canis F; Fruchart A; Bissinger MC; Dugimont JC; Nolf C; Hacot C; Gautier S; Chantrel J; Jousse M; Desseauve D; Plennevaux JL; Delaeter C; Deghilage S; Personne A; Joyez E; Guinard E; Kipnis E; Faure K; Grandbastien B; Ancel PY; Goffinet F; Dessein R
    Lancet; 2018 Nov; 392(10160):2171-2179. PubMed ID: 30322724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal administration of vaginal progesterone and frequency of uterine contractions in asymptomatic twin pregnancies.
    de Oliveira LA; Brizot ML; Liao AW; Bittar RE; Francisco RP; Zugaib M
    Acta Obstet Gynecol Scand; 2016 Apr; 95(4):436-43. PubMed ID: 26669629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical Pessary and Vaginal Progesterone in Twin Pregnancies With a Short Cervix.
    Fox NS; Gupta S; Lam-Rachlin J; Rebarber A; Klauser CK; Saltzman DH
    Obstet Gynecol; 2016 Apr; 127(4):625-630. PubMed ID: 26959202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
    Maerdan M; Shi C; Zhang X; Fan L
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical Pessary Compared With Vaginal Progesterone for Preventing Early Preterm Birth: A Randomized Controlled Trial.
    Cruz-Melguizo S; San-Frutos L; Martínez-Payo C; Ruiz-Antorán B; Adiego-Burgos B; Campillos-Maza JM; García-González C; Martínez-Guisasola J; Pérez-Carbajo E; Teulón-González M; Avendaño-Solá C; Pérez-Medina T
    Obstet Gynecol; 2018 Oct; 132(4):907-915. PubMed ID: 30204689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-pregnancy events and subsequent antenatal, delivery and neonatal outcomes: prospective cohort study.
    Al-Memar M; Vaulet T; Fourie H; Nikolic G; Bobdiwala S; Saso S; Farren J; Pipi M; Van Calster B; de Moor B; Stalder C; Bennett P; Timmerman D; Bourne T
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):530-537. PubMed ID: 30887596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.
    Mumford SL; Silver RM; Sjaarda LA; Wactawski-Wende J; Townsend JM; Lynch AM; Galai N; Lesher LL; Faraggi D; Perkins NJ; Schliep KC; Zarek SM; Schisterman EF
    Hum Reprod; 2016 Mar; 31(3):657-65. PubMed ID: 26759138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.